Edison raises $20 million in F round

Edison Pharmaceuticals Inc. (Mountain View, Calif.) raised $20 million in a series F round led by Mitsui & Co. Edison's lead compound is EPI-743, an oral small molecule targeting NAD(P)H dehydrogenase...